• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于操纵人类线粒体DNA异质性的工程化线粒体锌指核酸酶

Engineered mtZFNs for Manipulation of Human Mitochondrial DNA Heteroplasmy.

作者信息

Gammage Payam A, Van Haute Lindsey, Minczuk Michal

机构信息

MRC Mitochondrial Biology Unit, Wellcome Trust/MRC Building, Hills Road, Cambridge, CB2 0XY, UK.

出版信息

Methods Mol Biol. 2016;1351:145-62. doi: 10.1007/978-1-4939-3040-1_11.

DOI:10.1007/978-1-4939-3040-1_11
PMID:26530680
Abstract

Enrichment of desired mitochondrial DNA (mtDNA) haplotypes, in both experimental systems and the clinic, is an end sought by many. Through use of a designer nuclease platform optimized for delivery to mitochondria-the mitochondrially targeted zinc finger-nuclease (mtZFN)-it is possible to discriminate between mtDNA haplotypes with specificity to the order of a single nucleotide substitution. Site-specific cleavage of DNA produces a shift in the heteroplasmic ratio in favor of the untargeted haplotype. Here, we describe protocols for assembly of paired, conventional tail-tail mtZFN constructs and experimental approaches to assess mtZFN activity in mammalian cell cultures.

摘要

在实验系统和临床中,富集所需的线粒体DNA(mtDNA)单倍型是许多人追求的目标。通过使用针对线粒体递送进行优化的设计核酸酶平台——线粒体靶向锌指核酸酶(mtZFN),可以区分mtDNA单倍型,其特异性可达单核苷酸取代水平。DNA的位点特异性切割会导致异质性比例发生变化,有利于未靶向的单倍型。在这里,我们描述了配对的传统尾对尾mtZFN构建体的组装方案以及评估哺乳动物细胞培养物中mtZFN活性的实验方法。

相似文献

1
Engineered mtZFNs for Manipulation of Human Mitochondrial DNA Heteroplasmy.用于操纵人类线粒体DNA异质性的工程化线粒体锌指核酸酶
Methods Mol Biol. 2016;1351:145-62. doi: 10.1007/978-1-4939-3040-1_11.
2
Enhanced Manipulation of Human Mitochondrial DNA Heteroplasmy In Vitro Using Tunable mtZFN Technology.使用可调谐线粒体锌指核酸酶技术在体外增强对人类线粒体DNA异质性的操控
Methods Mol Biol. 2018;1867:43-56. doi: 10.1007/978-1-4939-8799-3_4.
3
Manipulation of Murine Mitochondrial DNA Heteroplasmy with mtZFNs.利用 mtZFNs 对小鼠线粒体 DNA 异质性的操作。
Methods Mol Biol. 2023;2615:329-344. doi: 10.1007/978-1-0716-2922-2_23.
4
Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs.通过使用线粒体锌指核酸酶(mtZFNs)进行迭代或动态剂量控制治疗,近乎完全消除突变型线粒体DNA(mtDNA)。
Nucleic Acids Res. 2016 Sep 19;44(16):7804-16. doi: 10.1093/nar/gkw676. Epub 2016 Jul 27.
5
Delivery of mtZFNs into Early Mouse Embryos.将线粒体锌指核酸酶导入早期小鼠胚胎。
Methods Mol Biol. 2018;1867:215-228. doi: 10.1007/978-1-4939-8799-3_16.
6
Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations.线粒体靶向锌指核酸酶用于选择性降解携带大规模缺失或点突变的致病性线粒体基因组。
EMBO Mol Med. 2014 Apr;6(4):458-66. doi: 10.1002/emmm.201303672. Epub 2014 Feb 24.
7
Therapeutic Manipulation of mtDNA Heteroplasmy: A Shifting Perspective.线粒体DNA异质性的治疗性调控:视角转变
Trends Mol Med. 2020 Jul;26(7):698-709. doi: 10.1016/j.molmed.2020.02.006. Epub 2020 Mar 26.
8
Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.用于选择性降解突变型人类线粒体DNA的单链准二聚体锌指核酸酶的研发。
Nucleic Acids Res. 2008 Jul;36(12):3926-38. doi: 10.1093/nar/gkn313. Epub 2008 May 29.
9
Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease.通过线粒体靶向限制性内切酶操纵线粒体DNA异质性。
Hum Mol Genet. 2001 Dec 15;10(26):3093-9. doi: 10.1093/hmg/10.26.3093.
10
Modulating Mitochondrial DNA Heteroplasmy with Mitochondrially Targeted Endonucleases.用靶向线粒体的核酸内切酶调节线粒体 DNA 异质性
Ann Biomed Eng. 2024 Sep;52(9):2627-2640. doi: 10.1007/s10439-022-03051-7. Epub 2022 Aug 24.

引用本文的文献

1
Preclinical models of mitochondrial dysfunction: mtDNA and nuclear-encoded regulators in diverse pathologies.线粒体功能障碍的临床前模型:不同病理学中的线粒体DNA和核编码调节因子
Front Aging. 2025 Jun 23;6:1585508. doi: 10.3389/fragi.2025.1585508. eCollection 2025.
2
Integrating Mitochondrial Biology into Innovative Cell Therapies for Neurodegenerative Diseases.将线粒体生物学融入神经退行性疾病的创新细胞疗法
Brain Sci. 2024 Sep 5;14(9):899. doi: 10.3390/brainsci14090899.
3
Harnessing accurate mitochondrial DNA base editing mediated by DdCBEs in a predictable manner.
以可预测的方式利用由DdCBE介导的精确线粒体DNA碱基编辑。
Front Bioeng Biotechnol. 2024 Apr 9;12:1372211. doi: 10.3389/fbioe.2024.1372211. eCollection 2024.
4
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma.线粒体 DNA 突变驱动有氧糖酵解以增强黑色素瘤的检查点封锁反应。
Nat Cancer. 2024 Apr;5(4):659-672. doi: 10.1038/s43018-023-00721-w. Epub 2024 Jan 29.
5
Mitochondrial DNA is a major source of driver mutations in cancer.线粒体 DNA 是癌症驱动突变的主要来源。
Trends Cancer. 2022 Dec;8(12):1046-1059. doi: 10.1016/j.trecan.2022.08.001. Epub 2022 Aug 27.
6
Rapamycin rescues mitochondrial dysfunction in cells carrying the m.8344A > G mutation in the mitochondrial tRNA.雷帕霉素挽救携带线粒体 tRNA m.8344A > G 突变的细胞中线粒体功能障碍。
Mol Med. 2022 Aug 3;28(1):90. doi: 10.1186/s10020-022-00519-z.
7
Understanding Inborn Errors of Metabolism through Metabolomics.通过代谢组学理解先天性代谢缺陷
Metabolites. 2022 Apr 27;12(5):398. doi: 10.3390/metabo12050398.
8
Interrogating Mitochondrial Biology and Disease Using CRISPR/Cas9 Gene Editing.利用CRISPR/Cas9基因编辑技术探究线粒体生物学与疾病
Genes (Basel). 2021 Oct 12;12(10):1604. doi: 10.3390/genes12101604.
9
Adapting CRISPR/Cas9 System for Targeting Mitochondrial Genome.改造CRISPR/Cas9系统以靶向线粒体基因组。
Front Genet. 2021 Apr 6;12:627050. doi: 10.3389/fgene.2021.627050. eCollection 2021.
10
METTL15 introduces N4-methylcytidine into human mitochondrial 12S rRNA and is required for mitoribosome biogenesis.METTL15 将 N4-甲基胞嘧啶引入人线粒体 12S rRNA 中,并且是线粒体核糖体生物发生所必需的。
Nucleic Acids Res. 2019 Nov 4;47(19):10267-10281. doi: 10.1093/nar/gkz735.